FBTU.L vs. SBIO
Compare and contrast key facts about First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating (FBTU.L) and ALPS Medical Breakthroughs ETF (SBIO).
FBTU.L and SBIO are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FBTU.L is managed by First Trust. SBIO is a passively managed fund by SS&C that tracks the performance of the S-Network Medical Breakthroughs Index. It was launched on Dec 31, 2014.
Performance
FBTU.L vs. SBIO - Performance Comparison
Loading graphics...
FBTU.L vs. SBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
FBTU.L First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating | -2.90% | 25.95% | 4.74% | 3.91% | -5.96% | -3.77% | 3.88% |
SBIO ALPS Medical Breakthroughs ETF | 3.20% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 23.45% |
Returns By Period
In the year-to-date period, FBTU.L achieves a -2.90% return, which is significantly lower than SBIO's 3.20% return.
FBTU.L
- 1D
- 2.68%
- 1M
- -0.84%
- YTD
- -2.90%
- 6M
- 9.93%
- 1Y
- 21.23%
- 3Y*
- 9.77%
- 5Y*
- 4.48%
- 10Y*
- —
SBIO
- 1D
- 0.99%
- 1M
- 3.89%
- YTD
- 3.20%
- 6M
- 36.23%
- 1Y
- 95.78%
- 3Y*
- 26.37%
- 5Y*
- 1.76%
- 10Y*
- 9.75%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBTU.L vs. SBIO - Expense Ratio Comparison
FBTU.L has a 0.60% expense ratio, which is higher than SBIO's 0.50% expense ratio.
Return for Risk
FBTU.L vs. SBIO — Risk / Return Rank
FBTU.L
SBIO
FBTU.L vs. SBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating (FBTU.L) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBTU.L | SBIO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.92 | 2.92 | -2.01 |
Sortino ratioReturn per unit of downside risk | 1.39 | 3.57 | -2.18 |
Omega ratioGain probability vs. loss probability | 1.17 | 1.45 | -0.28 |
Calmar ratioReturn relative to maximum drawdown | 1.58 | 5.66 | -4.08 |
Martin ratioReturn relative to average drawdown | 4.69 | 19.94 | -15.25 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBTU.L | SBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.92 | 2.92 | -2.01 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.22 | 0.05 | +0.16 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.29 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.18 | 0.23 | -0.04 |
Correlation
The correlation between FBTU.L and SBIO is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
FBTU.L vs. SBIO - Dividend Comparison
Neither FBTU.L nor SBIO has paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBTU.L First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
Drawdowns
FBTU.L vs. SBIO - Drawdown Comparison
The maximum FBTU.L drawdown since its inception was -33.73%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for FBTU.L and SBIO.
Loading graphics...
Drawdown Indicators
| FBTU.L | SBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -33.73% | -63.06% | +29.33% |
Max Drawdown (1Y)Largest decline over 1 year | -14.30% | -15.08% | +0.78% |
Max Drawdown (5Y)Largest decline over 5 years | -29.97% | -53.67% | +23.70% |
Max Drawdown (10Y)Largest decline over 10 years | — | -63.06% | — |
Current DrawdownCurrent decline from peak | -9.15% | -13.79% | +4.64% |
Average DrawdownAverage peak-to-trough decline | -13.30% | -28.70% | +15.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.82% | 4.28% | +0.54% |
Volatility
FBTU.L vs. SBIO - Volatility Comparison
The current volatility for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating (FBTU.L) is 7.44%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 12.61%. This indicates that FBTU.L experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBTU.L | SBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.44% | 12.61% | -5.17% |
Volatility (6M)Calculated over the trailing 6-month period | 15.12% | 22.09% | -6.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.07% | 33.43% | -10.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.73% | 33.55% | -12.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.28% | 33.34% | -12.06% |